Osborne Matthew Scott 4
4 · Unum Therapeutics Inc. · Filed Jun 25, 2019
Insider Transaction Report
Form 4
Osborne Matthew Scott
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-06-24+190,000→ 190,000 totalExercise: $2.44Exp: 2029-06-24→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest as follows: 25% on the first anniversary of the date of grant then in equal monthly installments over 36 months.